XML 126 R111.htm IDEA: XBRL DOCUMENT v3.20.4
Segment Reporting - Reconciliation of Adjusted EBITDA (Details) - USD ($)
 3 Months Ended 12 Months Ended
Dec. 31, 2020
Sep. 30, 2020
Jun. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]                      
General and administrative expenses                 $ (155,500,000) $ (247,000,000.0) $ (220,200,000)
Depreciation and amortization                 (243,000,000.0) (218,700,000) (199,700,000)
Government, class action, and related settlements                 (2,800,000) 0 (52,000,000.0)
Loss on early extinguishment of debt                 (2,300,000) (7,700,000) 0
Net income attributable to noncontrolling interests $ (25,700,000) $ (22,400,000) $ (14,800,000) $ (21,700,000) $ (22,600,000) $ (21,900,000) $ (19,700,000) $ (22,900,000) (84,600,000) (87,100,000) (83,100,000)
Gain on consolidation of joint venture formerly accounted for under the equity method of accounting                 0 19,200,000 0
Income from continuing operations before income tax expense                 472,600,000 562,300,000 493,200,000
Inpatient Rehabilitation Hospital and Home Health and Hospice                      
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]                      
Total Segment Adjusted EBITDA                 986,300,000 1,095,400,000 1,034,300,000
Segment Reconciling Items                      
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]                      
General and administrative expenses                 (155,500,000) (247,000,000.0) (220,200,000)
Depreciation and amortization                 (243,000,000.0) (218,700,000) (199,700,000)
Loss on disposal or impairment of assets                 (11,600,000) (11,100,000) (5,700,000)
Government, class action, and related settlements                 (2,800,000) 0 (52,000,000.0)
Loss on early extinguishment of debt                 (2,300,000) (7,700,000) 0
Interest expense and amortization of debt discounts and fees                 (184,200,000) (159,700,000) (147,300,000)
Net income attributable to noncontrolling interests                 84,600,000 87,100,000 83,100,000
SARs mark-to-market impact on noncontrolling interests                 0 5,000,000.0 2,600,000
Change in fair market value of equity securities                 400,000 800,000 (1,900,000)
Gain on consolidation of joint venture formerly accounted for under the equity method of accounting                 2,200,000 19,200,000 0
Payroll taxes on SARs exercise                 $ (1,500,000) $ (1,000,000.0) $ 0